Meridian Bioscience/ US5895841014 /
2023-01-30 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
33.98USD | - | 112,605 Turnover: 3.83 mill. |
-Bid Size: - | -Ask Size: - | 1.5 bill.USD | - | 35.02 |
Assets
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 26.5000 | 26.2000 | 26.1000 | 27.6100 | 27.4920 | ||||||
Intangible Assets | 10.9000 | 10.3000 | 8.1000 | 7.8130 | 5.9310 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | 64.1810 | 60.4290 | ||||||
Inventories | 32.7000 | 31.7000 | 34.8000 | 35.4950 | 35.8170 | ||||||
Accounts Receivable | 24.8000 | 24.2000 | 26.2000 | 23.2320 | 26.2540 | ||||||
Cash and Cash Equivalents | 23.6000 | 31.6000 | 44.3000 | 43.0470 | 49.9730 | ||||||
Current Assets | 90.4000 | 96.6000 | 114.1000 | 112.7480 | 122.8530 | ||||||
Total Assets | 155.5000 | 161.4000 | 176.7000 | 176.9290 | 183.2820 |
Liabilities
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 5.5000 | 5.8000 | 5.6000 | 4.9660 | 6.6460 | ||||||
Long-term debt | - | - | - | 0.0000 | 0.0000 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 1.7000 | .2000 | - | - | - | ||||||
Liabilities | 17 | 18.7000 | 21.7000 | 15.9000 | 17.4090 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 138.5000 | 142.7000 | 155 | 161.0290 | 165.8730 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 155.5000 | 161.4000 | 176.7000 | 176.9290 | 183.2820 |
Income Statement
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 159.7000 | 173.5000 | 188.7000 | 188.8320 | 194.8300 | ||||||
Depreciation (total) | - | - | - | 5.5620 | 5.2180 | ||||||
Operating Result | 40 | 49.3000 | 57.3000 | 52.3920 | 56.0600 | ||||||
Interest Income | .1000 | - | .0400 | .0250 | .0230 | ||||||
Income Before Taxes | 40.5000 | 49.7000 | 57.4000 | 52.1080 | 55.0630 | ||||||
Income Taxes | 13.7000 | 16.3000 | 19.3000 | 17.3650 | 19.5230 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 26.8000 | 33.4000 | 38 | 34.7430 | 35.5400 |
Per Share
Cash Flow
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 22.5000 | 42.4000 | 44.4000 | 38.2620 | 42.8090 | ||||||
Cash Flow from Investing Activities | -9.2000 | -4.4000 | -3.3000 | -7.0020 | -3.6260 | ||||||
Cash Flow from Financing | -27.5000 | -30.7000 | -28.6000 | -31.7530 | -30.7430 | ||||||
Decrease / Increase in Cash | -14.3000 | 8 | 12.7000 | -1.2350 | 6.9260 | ||||||
Employees | - | - | - | - | 580 |